1st Quarter - Report

TODD STRATEGY GROUP for BIODESIX, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Implementation of PO 113-93 (H.R. 4203): Protecting Access to Medicare Act of 2014. Implementation of changes to Medicare payments for clinical laboratory tests.

LobbyistCovered position, as disclosed
DANIEL M TODD Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid

Bills named: H.R. 4203 (114th)

Medical/Disease Research/Clinical Labs MED

21st Century Cures Initiative.

LobbyistCovered position, as disclosed
DANIEL M TODD —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.